Literature DB >> 22096086

A possible role for perforin and granzyme B in resveratrol-enhanced radiosensitivity of prostate cancer.

Yujiang Fang1, Elizabeth J Herrick, Michael B Nicholl.   

Abstract

Perforin and granzyme B are expressed primarily by activated lymphocytes (cytotoxic T cells, natural killer cells, and natural killer T cells) and function together to induce apoptosis of target cells. Typically, these proteins are not expressed in tumor cells. In the present study, we established the constitutive expression of perforin and granzyme B by the PC-3 and DU145 prostate cancer (PCA) cell lines with reverse transcription polymerase chain reaction, immunohistochemistry, Western blot, or a combination of techniques. The combination of radiation and resveratrol (XRT/RSV) additively/synergistically decreased survival of PCA because, at least in part, of increased apoptosis. We further demonstrated that treatment with RSV up-regulated the expression of both perforin and granzyme B, whereas treatment with XRT up-regulated the expression of granzyme B, but not that of perforin. Combined XRT/RSV treatment of PCA cells further increased the expression of both perforin and granzyme B compared with RSV or XRT alone. Thus, increased radiosensitivity of prostate cancer cells induced by RSV correlated with up-regulation of perforin and granzyme B, demonstrating a possible mechanism for tumor apoptosis. These findings might be helpful in devising new strategies for treating PCA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22096086     DOI: 10.2164/jandrol.111.015164

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  10 in total

1.  Prostate cancer: resveratrol and apoptotic proteins enhance radiosensitivity.

Authors:  Annette Fenner
Journal:  Nat Rev Urol       Date:  2012-01-17       Impact factor: 14.432

2.  The novel role of IL-37 in prostate cancer: evidence as a promising radiosensitizer.

Authors:  Vivi A Ding; Ziwen Zhu; Timothy A Steele; Mark R Wakefield; Huaping Xiao; Dean Balabanov; Yujiang Fang
Journal:  Med Oncol       Date:  2017-12-05       Impact factor: 3.064

3.  Trichomonas vaginalis: a possible foe to prostate cancer.

Authors:  Ziwen Zhu; Kristoffer T Davidson; Andrew Brittingham; Mark R Wakefield; Qian Bai; Huaping Xiao; Yujiang Fang
Journal:  Med Oncol       Date:  2016-09-08       Impact factor: 3.064

Review 4.  Dietary polyphenols in prevention and treatment of prostate cancer.

Authors:  Rahul K Lall; Deeba N Syed; Vaqar M Adhami; Mohammad Imran Khan; Hasan Mukhtar
Journal:  Int J Mol Sci       Date:  2015-02-03       Impact factor: 5.923

Review 5.  Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis.

Authors:  Francesca Velotti; Ilaria Barchetta; Flavia Agata Cimini; Maria Gisella Cavallo
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

6.  DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β-catenin pathway in colorectal cancer.

Authors:  Sumit Agarwal; Farrukh Afaq; Prachi Bajpai; Hyung-Gyoon Kim; Amr Elkholy; Michael Behring; Darshan Shimoga Chandrashekar; Sameer Al Diffalha; Moh'd Khushman; Shajan P Sugandha; Sooryanarayana Varambally; Upender Manne
Journal:  Mol Oncol       Date:  2022-03-07       Impact factor: 7.449

Review 7.  Resveratrol in prostate diseases - a short review.

Authors:  Milosz Jasiński; Lidia Jasińska; Marcin Ogrodowczyk
Journal:  Cent European J Urol       Date:  2013-08-13

8.  Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs.

Authors:  Joel D Pearson; Jingxi Zhang; Zuoqiao Wu; Kayla D Thew; Katelynn J Rowe; Julinor T C Bacani; Robert J Ingham
Journal:  Mol Cancer       Date:  2014-08-29       Impact factor: 27.401

9.  Epitelial-to-mesenchimal transition and invasion are upmodulated by tumor-expressed granzyme B and inhibited by docosahexaenoic acid in human colorectal cancer cells.

Authors:  Donatella D'Eliseo; Giuliana Di Rocco; Rossella Loria; Silvia Soddu; Angela Santoni; Francesca Velotti
Journal:  J Exp Clin Cancer Res       Date:  2016-02-02

10.  Early synergistic interactions between the HPV16‑E7 oncoprotein and 17β-oestradiol for repressing the expression of Granzyme B in a cervical cancer model.

Authors:  J Antonio Munguía-Moreno; José Díaz-Chavéz; Enrique García-Villa; M Estela Albino-Sanchez; Daniel Mendoza-Villanueva; Rodolfo Ocadiz-Delgado; José Bonilla-Delgado; Armando Marín-Flores; Enoc M Cortés-Malagón; Elizabeth Alvarez-Rios; Alfredo Hidalgo-Miranda; Aykut Üren; Haydar Çelik; Paul F Lambert; Patricio Gariglio
Journal:  Int J Oncol       Date:  2018-06-06       Impact factor: 5.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.